How to integrate stereotactic body radiation therapy and hypofractionation in the management of stage III lung cancer in the age of immunotherapy
The constant advances in the field of lung cancer immunotherapy have recently reached the treatment of locally advanced disease with the approval of durvalumab after concurrent chemoradiation. However, radiation therapy continues to be key for controlling the disease at this stage. Over the years, d...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Departamento de Salud del Gobierno de Navarra (Health Department, Goverment of Navarra)
2020-08-01
|
| Colección: | Anales del Sistema Sanitario de Navarra |
| Materias: | |
| Acceso en línea: | https://recyt.fecyt.es/index.php/ASSN/article/view/74609 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|